Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead …Business Wire (press release)A robust deal-making market has enabled gene therapy drug development to be advanced and adequately funded thr… Continue reading
Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead …Business Wire (press release)A robust deal-making market has enabled gene therapy drug development to be advanced and adequately funded thr… Continue reading
SpectrumCRISPR tweak fixes genetic flaw in fragile X syndromeSpectrumA modified version of the genetic engineering tool CRISPR restores expression of the gene mutated in fragile X syndrome, a new stem-cell study suggests. In particular, the tweak enabl… Continue reading
The Financial AnalystGlobal Synthetic Biology Market 2018 by Manufacturer – Amyris, DuPont, GenScript USAThe Financial AnalystThis Synthetic Biology Market report comprehends outline in Global market, especially in North America, Europe and Asia.It foc… Continue reading
Phys.OrgScientists discover function of Cas4 protein in CRISPR-Cas defence systemsPhys.OrgResearchers around the globe have increasingly been using a bacterial defence mechanism called CRISPR-Cas9 as a tool to surgically edit DNA in living cells. This … Continue reading
Synthetic Biology Workstation Market to Grow at 7.02% CAGR by 2021: Impact of Drivers, Industry Trends, Analysis and …Pharmaceuticals NewsThe Synthetic Biology Workstation Market research report is a professional and in-depth study on the current sta… Continue reading
News-Medical.netManipulating RNA sequences using CRISPR-Cas13News-Medical.netThe traditional CRISPR-Cas system is the Cas-9 system, first identified in Streptococcus Thermophilus. Once cas-9 is introduced into the cells, special designed guide RNA is u… Continue reading
|
CAR–T is a personalized attack on cancer. Here’s how it works
STAT he immune system constantly scans the body for tumor cells, destroying most of them before they can become a detectable cancer, but sometimes it needs a boost. That’s the thinking behind the new generation of cancer treatments called immunotherapies … |